AWH Aspira Women's Health Inc.
Healthcare$0.08-15.90%ClosedMarket Cap: $2.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.57
P/S
0.28
EV/EBITDA
-0.42
DCF Value
$-34.47
FCF Yield
-175.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
60.9%
Operating Margin
-77.2%
Net Margin
-115.1%
ROE
203.3%
ROA
-201.5%
ROIC
12501.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.0M | 54.4% | $-2.2M | $676.0K | $— | — |
| Q4 null | $2.2M | 64.5% | $-1.3M | $-3.4M | $— | — |
| FY null | $9.2M | 64.2% | $-7.9M | $-12.8M | $— | — |
| Q3 null | $2.3M | 60.0% | $-1.6M | $-4.9M | $— | — |
| Q2 null | $2.4M | 63.8% | $-1.8M | $-2.7M | $— | — |
| Q1 null | $2.3M | 68.5% | $-3.2M | $-1.9M | $— | — |
| Q4 null | $2.3M | 63.4% | $-3.4M | $-1.4M | $— | — |
| FY null | $9.2M | 59.7% | $-16.3M | $-13.1M | $— | — |
| Q3 null | $2.3M | 60.0% | $-3.7M | $-3.5M | $— | — |
| Q2 null | $2.4M | 58.6% | $-4.4M | $-3.5M | $— | — |
| Q1 null | $2.2M | 56.4% | $-4.7M | $-4.6M | $— | — |
| Q4 2023 | $2.1M | 57.2% | $-4.1M | $-3.1M | $-0.30 | — |